Malaria continues to place a substantial burden on many emerging economies, contributing to significant loss of life, ...
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...
Malaria vaccine shows over 50% efficacy in adults following controlled human malaria infection, supporting further trials in children.
KAE609 (cipargamin; formerly NITD609, Novartis Institute for Tropical Diseases) is a new synthetic antimalarial spiroindolone analogue with potent, dose-dependent antimalarial activity against asexual ...
Los síntomas principales del paludismo ‒ fiebre, cansancio, malestar y dolores corporales ‒ suelen aparecer entre 10 y 15 días después de que el parásito causante de la enfermedad, el protozoo del ...
Calcium is essential for the correct functioning of the cell and requires regulation to avoid high concentrations causing cell death. Calcium ions are important for cell signaling as the binding of ...
The evolutionary path of the deadliest human malaria parasite, Plasmodium falciparum, has been revealed for the first time. This parasite is a member of the Laverania parasite family that only infect ...
Scientists have identified the regional character to Plasmodium falciparum across Africa. Malaria, infecting 219 million individuals in 2017, remains a threat to public health and regional stability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback